6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo‐Yong Hahn, Byung Ok Kim, Jang Hyun Cho et al.|The Lancet|2018Cited by 372
Ischemic Postconditioning During Primary Percutaneous Coronary InterventionJoo‐Yong Hahn, Hyeon‐Cheol Gwon, Young Bin Song et al.|Circulation|2013Cited by 166
Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trialJoo‐Yong Hahn, Hyeon‐Cheol Gwon, Cheol Woong Yu et al.|American Heart Journal|2015Cited by 26
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Young Bin Song, Joo‐Yong Hahn et al.|Cardiology Journal|2021Cited by 23
The clinical impact of sex differences on ischemic postconditioning during primary percutaneous coronary intervention: a POST (the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction) substudyEun‐Seok Shin, Hun Sik Park, Ju-Hyun Chung et al.|Heart and Vessels|2018Cited by 6